AIBusinessHealthcareInnovation & PioneersReportsTop News

Siemens Healthineers Initiates Carve-Out of In Vitro Diagnostics Business, Rebranding as Olyrian Diagnostics

Siemens Healthineers has announced the initiation of the carve-out process to establish its in vitro diagnostics business as a standalone organization operating under the new name Olyrian Diagnostics. Occurring in parallel with Siemens Healthineers’ own corporate rebrand to Healthineers, the transition is expected to be completed by mid-2028, positioning Olyrian as one of the world’s largest dedicated diagnostics-focused companies.

 

Guided by its core purpose—”Powering human potential at the heart of care”—Olyrian Diagnostics will advance diagnostic solutions across the entire care continuum, spanning laboratory automation, informatics, and point-of-care testing from patient draw to population health. Commenting on the milestone, Sharon Bracken, Head of Diagnostics for Siemens Healthineers, emphasized that while technology creates possibilities, people turn them into better patient outcomes through informed and connected workflows.

 

Building on a century-long legacy of innovation and manufacturing over 16 billion tests annually across major disease areas, Olyrian will remain part of Siemens Healthineers throughout the phased rollout. Customers will experience zero immediate changes to existing products, contracts, service levels, or points of contact as the business prepares for its next chapter as an independent market leader.

Related Articles

Back to top button